Shares of Heartflow (HTFL +35.70%) jumped on Friday after the medical diagnostics specialist boosted its full-year revenue targets.
Image source: Getty Images.
Hearty growth
Coronary artery disease is the leading cause of death worldwide. Heartflow is working to make it a condition that can be accurately detected and effectively managed.
Its Heartflow One platform uses cutting-edge artificial intelligence (AI) to turn coronary images into personalized 3D models of the heart, providing doctors with a non-invasive way to locate plaque and ascertain its effect on blood flow.
Unsurprisingly, given these benefits, Heartflow's tech is in high demand. The company's revenue surged 48% year over year to $64.1 million in the second quarter.
NASDAQ: HTFL
Key Data Points
Moreover, Heartflow's profitability is improving as it scales its operations. Its adjusted gross margin increased to 83.3% from 75.6% in the year-ago period.
Investors should note that Heartflow is not yet profitable. But its adjusted operating loss did narrow to $7.9 million from $11.5 million in the prior-year quarter.
A path to sustained profitability
Heartflow now expects its full-year revenue to grow by 40%-42% to between $246 million and $250 million in 2026, up from a prior forecast of 29%-32% growth. Management also lifted its adjusted gross margin target to 82% from 81%.
"Record gross margin and improving operating leverage demonstrate the increasing scalability of our model, giving us greater confidence in long-term, profitable growth," CEO John Farquhar said.
